2023.03.07

Puls Biznesu: Genomtec wants to strengthen with a share issue

In February, the company announced plans for a share issue of up to 1.64 million shares, which will represent 14 percent of the company’s ...
2023.02.28

Genomtec S.A. intensifies M&A process

The management board of Genomtec S.A., a medical technology company, plans to raise additional funds to support maximization of the ...
2023.02.16

Genomtec S.A. debuted on the Main Market of the Warsaw Stock Exchange

On 16th February 2023, Genomtec S.A. debuted on the Main Market of the Warsaw Stock Exchange Video from the debut: ...
2023.02.09

Genomtec’s first listing on the Main Market of the Warsaw Stock Exchange

16 February 2023 – the date for Genomtec’s first listing on the Main Market of the Warsaw Stock Exchange. We have great pleasure to invite all ...
2023.01.25

Polish Financial Supervision Authority approved the Genomtec S.A. prospectus

In the next few days, the company expects to apply to the Warsaw Stock Exchange for admission and listing of Genomtec S.A. shares on the Warsaw ...
2023.01.10

Value of the intellectual property portfolio of Genomtec S.A. estimated at EUR 191.336 million

Genomtec S.A. received from the German company Dennemeyer Consulting GmbH a valuation of the Company’s intellectual property portfolio. ...